EMET prize for cancer research

Professor Zelig Eshhar of Israel’s Weizmann Institute and Professor Alexander Levitzki of Jerusalem’s Hebrew University shared the EMET Life Sciences award for their cancer research. Eshhar’s award was for his adaptive immunotherapy treatment; Levitski for his protein kinases inhibitors.


This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *